A Phase 1, First-in-human Study of VX-634

NCT05579431 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha 1-Antitrypsin Deficiency

Interventions

DRUG: VX-634
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated